Background: Ophthalmic clinicians report low confidence in telemedicine-based eye care delivery, but it may have changed given its rapid expansion during the coronavirus 2019 (COVID-19) pandemic. Introduction: The purpose of this study was to determine clinician confidence in telemedicine-based eye care services during COVID-19. Materials and Methods: An electronic survey was sent to clinicians at University of Michigan Kellogg Eye Center (April 17, 2020-May 6, 2020) when nonemergent in-person visits and procedures were restricted. The primary outcome was clinician confidence in using telemedicine-based eye care during COVID-19. Secondary outcomes included telemedicine utilization and its association with clinician confidence using Fisher's exact test. Results: Of the 88 respondents (90.7% response rate; n = 97 total), 83.0% (n = 73) were ophthalmologists and 17.0% (n = 15) were optometrists. Telemedicine utilization increased from 30.7% (n = 27) before the pandemic to 86.2% (n = 75) after the pandemic. Clinicians' confidence in their ability to use telemedicine varied with 28.6% (24/84) feeling confident/extremely confident, 38.1% (32/84) somewhat confident, and 33.3% (28/84) not-at-all confident. Most felt that telemedicine was underutilized (62.1%; 54/87) and planned continued use over the next year (59.8%; 52/87). Confident respondents were more likely to have performed three or more telemedicine visits (p = 0.003), to believe telemedicine was underutilized (p < 0.001), and to anticipate continued use of telemedicine (p = 0.009). Discussion: The majority of clinicians were at least somewhat confident about using telemedicine during the pandemic. Clinician confidence was associated with telemedicine visit volume and intention to continue using telemedicine. Conclusions: Policies that foster clinician confidence will be important to sustain telemedicine-based eye care delivery.
Background: Ophthalmic clinicians report low confidence in telemedicine-based eye care delivery, but it may have changed given its rapid expansion during the coronavirus 2019 (COVID-19) pandemic. Introduction: The purpose of this study was to determine clinician confidence in telemedicine-based eye care services during COVID-19. Materials and Methods: An electronic survey was sent to clinicians at University of Michigan Kellogg Eye Center (April 17, 2020-May 6, 2020) when nonemergent in-person visits and procedures were restricted. The primary outcome was clinician confidence in using telemedicine-based eye care during COVID-19. Secondary outcomes included telemedicine utilization and its association with clinician confidence using Fisher's exact test. Results: Of the 88 respondents (90.7% response rate; n = 97 total), 83.0% (n = 73) were ophthalmologists and 17.0% (n = 15) were optometrists. Telemedicine utilization increased from 30.7% (n = 27) before the pandemic to 86.2% (n = 75) after the pandemic. Clinicians' confidence in their ability to use telemedicine varied with 28.6% (24/84) feeling confident/extremely confident, 38.1% (32/84) somewhat confident, and 33.3% (28/84) not-at-all confident. Most felt that telemedicine was underutilized (62.1%; 54/87) and planned continued use over the next year (59.8%; 52/87). Confident respondents were more likely to have performed three or more telemedicine visits (p = 0.003), to believe telemedicine was underutilized (p < 0.001), and to anticipate continued use of telemedicine (p = 0.009). Discussion: The majority of clinicians were at least somewhat confident about using telemedicine during the pandemic. Clinician confidence was associated with telemedicine visit volume and intention to continue using telemedicine. Conclusions: Policies that foster clinician confidence will be important to sustain telemedicine-based eye care delivery.
Authors: Maria A Woodward; Patricia Ple-Plakon; Taylor Blachley; David C Musch; Paula Anne Newman-Casey; Lindsey B De Lott; Paul P Lee Journal: Telemed J E Health Date: 2015-01-30 Impact factor: 3.536
Authors: Akhila Balasubramanian; Sally W Wade; Robert A Adler; Kenneth Saag; Nicola Pannacciulli; Jeffrey R Curtis Journal: J Bone Miner Res Date: 2018-08-22 Impact factor: 6.741
Authors: Marina Serper; Allen W Cubell; Mary Elisabeth Deleener; Tara K Casher; Dale J Rosenberg; Dale Whitebloom; Roy M Rosin Journal: Hepatology Date: 2020-08 Impact factor: 17.425
Authors: Paula Anne Newman-Casey; Lindsey De Lott; Juno Cho; Dena Ballouz; Lyna Azzouz; Sahal Saleh; Maria A Woodward Journal: Am J Ophthalmol Date: 2021-05-01 Impact factor: 5.258
Authors: Adi M Al Owaifeer; Samar A Al-Swailem; Abdulaziz M Al Dehailan; Abdulrahman Al Naim; Mohammed F Al Molhim; Rajiv B Khandekar Journal: Cureus Date: 2022-04-05
Authors: Carly Stewart; Josephine Coffey-Sandoval; Erik A Souverein; Tiffany C Ho; Thomas C Lee; Sudha Nallasamy Journal: Clin Ophthalmol Date: 2022-09-01
Authors: Angelica C Scanzera; Arthur Y Chang; Nita Valikodath; Emily Cole; Joelle A Hallak; Thasarat Sutabutr Vajaranant; Sage J Kim; R V Paul Chan Journal: BMC Ophthalmol Date: 2021-09-24 Impact factor: 2.209
Authors: Carly Stewart; Josephine Coffey-Sandoval; Mark W Reid; Tiffany C Ho; Thomas C Lee; Sudha Nallasamy Journal: Br J Ophthalmol Date: 2021-03-15 Impact factor: 5.908